Abstract
Hypoxia is a characteristic property of locally advanced solid tumors, resulting from an imbalance between the supply and consumption of oxygen. Major pathogenetic mechanisms for the development of hypoxia are (1) structural and functional abnormalities of the tumor microvasculature, (2) increased diffusion distances, and (3) tumor-associated and therapy-induced anemia. The oxygenation status is independent of clinical tumor size, stage, grade, and histopathological type, but is affected by the hemoglobin level. Hypoxia is intensified in anemic patients, especially in tumors with low perfusion rates. Hypoxia and anemia (most probably via worsening of tumor hypoxia) can lead to therapeutic problems, as they make solid tumors resistant to sparsely ionizing radiation and some forms of chemotherapy. In addition to more direct mechanisms involved in the development of therapeutic resistance, there are also indirect machineries that can cause barriers to therapies. These include hypoxia-driven proteome and genome changes and clonal selection. These, in turn, can drive subsequent events that are known to further increase resistance to therapy (in addition to critically affecting long-term prognosis). Treatment resistance in anemic patients can be, at least partially, prevented or overcome by anemia correction, resulting in better locoregional tumor control and overall survival of patients.
Similar content being viewed by others
References
Vaupel, P., Schlenger, K., Knoop, C. and Hoeckel, M. (1991). Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51:3316–3322.
Hoeckel, M., Schlenger, K., Knoop, C. and Vaupel, P. (1991). Oxygenation of carcinomas of the uterine cervix: evaluation of computerized O2 tension measurements. Cancer Res. 51:6098–6102.
Vaupel, P. and Kelleher, D. K. (eds). (1999). Tumor Hypoxia. Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Höckel, M. and Vaupel, P. (2001). Tumor hypoxia: definitions and current clinical, biological and molecular aspects. J. Natl. Cancer Inst. 93:266–276.
Höckel, M., et al. (1993). Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26:45–50.
Höckel, M., et al. (1996). Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:4509–4515.
Höckel, M., Schlenger, K., Höckel, S. and Vaupel, P. (1999). Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res. 59:4525–4528.
Sundfor, K., Lyng, H. and Rofstad, E. K. (1998). Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br. J. Cancer 78:822–827.
Fyles, A. W., et al. (1998). Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 48:149–156.
Knocke, T. H., Weitmann, H.-D., Feldmann, H.-J., Selzer, E. and Pötter, S. (1999). Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother. Oncol. 53:99–104.
Sundfor, K., Lyng, H., Tropé, C. G. and Rofstad, E. K. (2000). Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother. Oncol. 54:101–107.
Nordsmark, M., Overgaard, M. and Overgaard, J. (1996). Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41:31–39.
Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L. and Dewhirst, M. W. (1997). Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38:285–289.
Stadler, P., et al. (1999). Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 44:749–754.
Nordsmark, M. and Overgaard, J. (2000). A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother. Oncol. 57:39–43.
Brizel, D. M., et al. (1996). Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:941–943.
Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A. and Workman, P. (1994). Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29:427–431.
Collingridge, D. R., Piepmeier, J. M., Rockwell, S. and Knisely, J. P. S. (1999). Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother. Oncol. 53:127–131.
Movsas, B., et al. (1999). Hypoxic regions exist in human prostate carcinoma. Urology 53:11–18.
Movsas, B., et al. (2000). Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age. Cancer 89:2018–2024.
Aquino-Parsons, C., Green, A. and Minchinton, A. I. (2000). Oxygen tension in primary gynaecological tumours: the influence of carbon dioxide concentration. Radiother. Oncol. 57:45–51.
Lyng, H., Sundfor, K. and Rofstad, E. K. (2000). Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 46:935–946.
Dunst, J., Hänsgen, G., Lautenschläger, C., Füchsel, G. and Becker, A. (1999). Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon. Int. J. Radiat. Oncol. Biol. Phys. 43:367–373.
Becker, A., et al. (2000). Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 46:459–466.
Lartigau, E., et al. (1997). Intratumoral oxygen tension in metastatic melanoma. Melanoma Res. 7:400–406.
Becker, A., et al. (1998). Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int. J. Radiat. Oncol. Biol. Phys. 42:35–41.
Vaupel, P. (2001). Durchblutung und Oxygenierungsstatus von Kopf-Hals-Tumoren, in Klinik des Rezidivtumors im Kopf-Hals-Bereich. Grundlagen — Diagnostik — Therapie. (H. D., Böttcher, T. G., Wendt, M. Henke, hrsg), pp 7–23. Zuckschwerdt, München.
Haensgen, G., et al. (2001). Tumor hypoxia, p53, and prognosis in cervical cancers. Int. J. Radiat. Oncol. Biol. Phys. 50:865–872.
Nordsmark, M., et al. (2001). Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 49:581–586.
Evans, S. M., et al. (2001). Hypoxia in human intraperitoneal and extremity sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 49:587–596.
Nordsmark, M., et al. (2001). Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br. J. Cancer 84:1070–1075.
Vaupel, P., Kelleher, D. K. and Höckel, M. (2001). Oxgenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin. Oncol. 28(Suppl. 8):29–35.
Vaupel, P. and Höckel, M. (2001). Hypoxie beim Zervixkarzinom: Pathogenese, Charakterisierung und biologische/klinische Konsequenzen. Zentralbl. Gynakol. 123:192–197.
Vaupel, P., Kallinowski, F. and Okunieff, P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res. 49:6449–6465.
Vaupel, P. W. (1994). Blood flow, oxygenation, tissue pH distribution and bioenergetic status of tumors. Ernst Schering Research Foundation Lecture 23.
Lyng, H., et al. (2001). Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy. Int. J. Cancer 96:182–190.
Jelkmann, W. (2000). Use of recombinant human erythropoietin as an antianemic and performance enhancing drug. Curr. Pharm. Biotech. 1:1–31.
Nowrousian, M. R. (1998). Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumors. Med. Oncol. 15(Suppl. 1):S19-S28.
Bron, D., Meuleman, N. and Mascaux, C. (2001). Biological basis of anemia. Semin. Oncol. 28(Suppl. 8):1–6.
Ludwig, H. and Fritze, E. (1998). Anemia in cancer patients. Semin. Oncol. 25:2–6.
Groopman, J. E. and Itri, L. M. (1999). Chemotherapy-induced anemia in adults: incidence and treatment. J. Natl. Cancer Inst. 91:1616–1634.
Groebe, K. (1999). Impact of anemia on the oxygenation status of tumors: a theoretical study, in Tumor Hypoxia. (P. Vaupel and D. K. Kelleher, eds), pp 75–82, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Kelleher, D. K., Matthiensen, U., Thews, O. and Vaupel, P. (1996). Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res. 56:4728–4734.
Kelleher, D. K., Matthiensen, U., Thews, O. and Vaupel, P. (1995). Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol. 34:379–384.
Vaupel, P., Thews, O., Kelleher, D. K. and Hoeckel, M. (1998). Oxygenation of human tumors: the Mainz experience. Strahlenther. Onkol. 174(Suppl. IV):6–12.
Thews, O. and Vaupel, P. (2001). Tumour hypoxia and anaemia: implications for the outcome of radiotherapy and chemotherapy. Focus Anaemia Cancer 2:59–65.
Brizel, D. M. (1999). Human tumor oxygenation: The Duke University Medical Center experience, in Tumor Hypoxia (P. Vaupel and D. K. Kelleher, eds), pp 29–38, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Dunst, J., Feldmann, H. J., Becker, A., Stadler, P., Hänsgen, G. and Molls, M. (1999). Oxygenation of human tumors: the Munich/Halle experience, in Tumor Hypoxia. (P. Vaupel and D. K. Kelleher, eds), pp 39–46, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Durand, R. E. (1991). Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. Int. J. Radiat. Oncol. Biol. Phys. 20:253–258.
Durand, R. E. (1994). The influence of microenvironmental factors during cancer therapy. In Vivo 8:691–702.
Teicher, B. A. (ed). (1993). Drug Resistance in Oncology. Marcel Dekker, New York.
Teicher, B. A. (1994). Hypoxia and drug resistance. Cancer Metastasis 13:139–168.
Teicher, B. A. (1995). Physiologic mechanisms of therapeutic resistance. Hematol. Oncol. Clin. North Am. 9:475–506.
Vaupel, P. (1997). The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia. Klin. Pädiatr. 209:243–249.
Chaplin, D. J., Horsman, M. R., Trotter, M. J. and Siemann, D. W. (2000). Therapeutic significance of microenvironmental factors. in Blood Perfusion and Microenvironment of Human Tumors. Implications for Clinical Radiooncology (M. Molls and P. Vaupel, eds), pp 133–134, Springer-Verlag, Berlin.
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S. and Scott, O. C. A. (1953). The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26:638–648.
Evans, J. C. and Bergsjö, P. (1965). The influence of anemia on the results of radiotherapy in carcinoma of the cervix. Radiology 84:709–717.
Bush, R. S. (1986). The significance of anemia in clinical radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 12:2047–2050.
Frommhold, H., Guttenberger, R. and Henke, M. (1998). The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther. Onkol. 174(Suppl. 4):31–34.
Henke, M., Momm, F. and Guttenberger, R. (1999). Erythropoietin for patients undergoing radiotherapy: the Freiburg experience, in Tumor Hypoxia (P. Vaupel and D. K. Kelleher, eds), pp 91–97, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Grau, C. and Overgaard, J. (2000). Significance of hemoglobin concentration for treatment outcome, in Blood Perfusion and Microenvironment of Human Tumors. Implications for Clinical Radiooncology. (M. Molls and P. Vaupel, eds), pp 101–112, Springer-Verlag, Berlin.
Kumar, P. (2000). Tumor hypoxia and anemia: Impact on the efficacy of radiation therapy. Semin. Hematol. 37:4–8.
Henke, M., Bechtold, C., Momm, F., Dörr, W. and Guttenberger, R. (2000). Blood hemoglobin level may affect radiosensitivity—preliminary results on acutely reacting normal tissues. Int. J. Radiat. Oncol. Biol. Phys. 48:339–345.
Dubray, B., et al. (1996). Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 201:553–558.
Grant, D. G., Hussain, A. and Hurman, D. (1999). Pretreatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy. J. Laryngol. Otol. 113:829–833.
Girinski, T., et al. (1989). Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int. J. Radiat. Oncol. Biol. Phys. 16:37–41.
Rudat, V., et al. (1999). Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother. Oncol. 53:119–125.
Thomas, G. (2001). The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin. Oncol. 28(Suppl. 8):60–65.
Glaser, C., et al. (2001). Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int. J. Radiat. Oncol. Biol. Phys. 50:705–715.
Dietz, A., et al. (2000). Prognostischer Stellenwert des Hämoglobinwertes vor primärer Radiochemotherapy von Kopf-Hals-Karzinomen. HNO 48:655–664.
Lutterbach, J. and Guttenberger, R. (2000). Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. Int. J. Radiat. Oncol. Biol. Phys. 48:1345–1350.
Thews, O., Koenig, R., Kelleher, D. K., Kutzner, J. and Vaupel, P. (1998). Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br. J. Cancer 78:752–756.
Kelleher, D. K., Thews, O. and Vaupel, P. (1999). Modulation of tumor oxygenation and radiosensitivity by erythropoietin, in Tumor Hypoxia (P. Vaupel and D. K. Kelleher, eds), pp 83–90, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Lavey, R. S. (1999). Clinical trial experience using erythropoietin during radiation therapy. in Tumor Hypoxia (P. Vaupel and D. K. Kelleher, eds), pp 99–105, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Teicher, B. A., Holden, S. A., Al-Achi, A. and Herman, T. S. (1990). Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSall murine fibrosarcoma. Cancer Res. 50:3339–3344.
Walker, L. J., Craig, R. B., Harris, A. L. and Hickson, I. D. (1994). A role for the human DNA-repair enzyme HAP1 in cellular-protection against DNA-damaging agents and hypoxic stress. Nucleic Acids Res. 22:4884–4889.
Chabner, B., Allegra, C. J., Curt, G. A. and Calabresi, P. (1996). Antineoplastic agents, in Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 9th ed., pp 1233–1287, McGraw-Hill, New York.
Sakata, K., et al. (1991). Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br. J. Cancer 64:809–814.
Hickman, J. A., Potten, C. S., Merritt, A. J. and Fisher, T. C. (1994). Apoptosis and cancer chemotherapy. Philos. Trans. R. Soc. B 345:319–325.
Thews, O., Kelleher, D. K. and Vaupel, P. (2001). Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res. 61:1358–1361.
Silver, D. F. and Piver, M. S. (1999). Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect. Gynecol. Oncol. 73:280–284.
Freitas, I. and Baronzio, G. F. (1991). Tumor hypoxia, reoxygenation and oxygenation strategies: possible role in photodynamic therapy. J. Photochem. Photobiol. B: Biol. 11:3–30.
Henderson, B. W. and Fingar, V. H. (1987). Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47:3110–3114.
Moan, J. and Sommer, S. (1985). Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res. 45:1608–1610.
Mitchell, J. B., et al. (1985). Oxygen dependence of hematoporphyrin derivative-induced photo-inactivation of Chinese hamster cells. Cancer Res. 45:2008–2011.
Chapman, J. D., et al. (1991). Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiat. Res. 126:73–79.
Vaupel, P. and Hoeckel, M. (2002). Tumor hypoxia and therapeutic resistance, in Recombinant Human Erythropoietin (rhEPO) in Clincial Oncology (M. R. Nowrousian, ed), Springer-Verlag, Berlin, in press.
Semenza, G. L. (2000). Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35:71–103.
Semenza, G. L. (2000). HIF-1: mediator of physiological and pathophysiological response to hypoxia. J. Appl. Physiol. 88:1474–1480.
Dachs, G. U. and Tozer, G. M. (2000). Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer 36:1649–1660.
Giaccia, A. J. (1996). Hypoxic stress proteins: survival of the fittest. Semin. Radiat. Oncol. 6:46–58.
Laderoute, K. R., Grant, T. D., Murphy, B. J. and Sutherland, R. M. (1992). Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen. Int. J. Cancer 52:428–432.
Sutherland, R. M. (1998). Tumor hypoxia and gene expression. Implications for malignant progression and therapy. Acta Oncol. 37:567–574.
Cheng, K. C. and Loeb, L. A. (1993). Genomic instability and tumor progression: mechanistic considerations. Adv. Cancer Res. 60:121–156.
De Jaeger, K., Kavanagh, M.-C. and Hill, R. P. (2001). Relationship of hypoxia to metastatic ability in rodent tumours. Br. J. Cancer 84:1280–1285.
Graeber, T. G., et al. (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88–91.
Kim, C. Y., et al. (1997). Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res. 57:4200–4204.
Reynolds, T. Y., Rockwell, S. and Glazer, P. M. (1996). Genetic instability induced by the tumor microenvironment. Cancer Res. 56:5754–5757.
Rofstad, E. K. (2000). Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 76:589–605.
Höckel, M., Schlenger K., Höckel, S. and Vaupel, P. (1999). Association between tumor hypoxia and malignant progression: the clinical evidence in cancer of the uterine cervix, in Tumor Hypoxia (P. Vaupel and D. K. Kelleher, eds), pp 65–74, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Höckel, M. and Vaupel, P. (2001). Biological consequences of tumor hypoxia. Semin. Oncol. 28(Suppl. 8):36–41.
Rofstad, E. K. and Maseide, K. (1999). Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int. J. Radiat. Biol. 75:1377–1393.
Thews, O., Kelleher, D. K. and Vaupel, P. (2001). Dynamics of tumor oxygenation and red blood cell flux in response to inspiratory hyperoxia combined with different levels of inspiratory hypercapnia. Radiother. Oncol. in press.
Aebersold, D. M., et al. (2001). Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61:2911–2916.
Ratcliffe, P. J., Pugh, C. W. and Maxwell, P. H. (2000). Targeting tumors through the HIF system. Nature Med. 6:1315–1316.
Kung, A. L., Wang, S., Klico, J. M., Kaelin, W. G. and Livingston, D. M. (2000). Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nature Med. 6:1335–1340.
Caro, J. J., Salas, M., Ward, A. and Goss, G. Anemia as an independent prognostic factor for survival in patients with cancer. Cancer 91: 2214–2221.
Dunst, J. (2001). The use of epoietin alfa to increase and maintain hemoglobin levels during radiotherapy. Semin. Oncol. 28(Suppl. 8):42–48.
Littlewood, T. J. (2001). The impact of hemoglobin levels on treatment outcomes in patients with cancer. Semin. Oncol. 28(Suppl. 8):49–53.
Wagner, W., et al. (2000). Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther. Onkol. 176:73–80.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vaupel, P., Thews, O. & Hoeckel, M. Treatment resistance of solid tumors. Med Oncol 18, 243–259 (2001). https://doi.org/10.1385/MO:18:4:243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:18:4:243